Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The previous government funding-status notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:16:11.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a system-wide notice about a lapse in government funding affecting site updates and directing users to cc.nih.gov and opm.gov for status. Updated the site to version v3.4.1 (from v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T00:40:25.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The changes are limited to UI and metadata updates (glossary display, new labels such as 'Last Update Submitted that Met QC Criteria', 'Last Update Posted', 'No FEAR Act Data', and revision 'v3.4.0'), with no changes to core study content, eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T22:53:48.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Site revision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T17:56:22.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Introduced a dedicated Locations section listing California, Missouri, and New York, replacing the previous per-state location entries; the page version updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T09:21:32.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Mia Weiss, M.D. was added as an investigator and Brian A. Van Tine, M.D., Ph.D. was removed from the study record.
    Difference
    0.4%
    Check dated 2025-12-16T03:06:36.000Z thumbnail image

Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.